title: Comparative analysis of humoral immune responses to HIV type 1 envelope glycoproteins in mice immunized with a DNA vaccine, recombinant Semliki Forest virus RNA, or recombinant Semliki Forest virus particles.
abstract: The Semliki Forest virus (SFV) system seems to be a useful new approach for generating effective immune responses against HIV-1 in animal models. We evaluated this system by comparing the humoral immune responses raised in mice immunized against the HIV-1 envelope with the SFV system, a DNA vaccine, and a recombinant Env glycoprotein. gp160 ELISA antibody titers (204,800) were highest in the sera from mice immunized with recombinant Semliki Forest virus particles. These sera contained antibodies to the CD4-binding site and recognized linear epitopes on gp120 and gp41 that were also recognized by a pool of sera from HIV1-infected individuals. This demonstrates that the HIV-1 envelope produced in vivo by the SFV system does not fold aberrantly. A low level of neutralizing antibodies against the HIV-1LAI strain was also detected in the serum of one mouse immunized with recombinant SFV particles, suggesting that booster injections should be given to achieve a more effective immune response. SFV recombinant particles induced the strongest humoral responses to the HIV-1 envelope of all the potential HIV env vaccines tested.
authors.affiliation: Laboratoire de Virologie, EP CNRS 117, Université François Rabelais, Tours, France.
authors.forename: D
authors.initials: D
authors.lastname: Brand
authors.forename: F
authors.initials: F
authors.lastname: Lemiale
authors.forename: I
authors.initials: I
authors.lastname: Turbica
authors.forename: L
authors.initials: L
authors.lastname: Buzelay
authors.forename: S
authors.initials: S
authors.lastname: Brunet
authors.forename: F
authors.initials: F
authors.lastname: Barin
mesh_terms: D016915:AIDS Vaccines / Q000008:administration & dosage / Q000235:genetics / Q000276:immunology*; D000818:Animals; D000917:Antibody Formation; D015483:HIV Antibodies / Q000097:blood / Q000276:immunology*; D019302:HIV Envelope Protein gp160 / Q000276:immunology*; D015497:HIV-1 / Q000276:immunology*; D051379:Mice; D009500:Neutralization Tests; D012367:RNA, Viral / Q000008:administration & dosage*; D012672:Semliki forest virus / Q000235:genetics; D019444:Vaccines, DNA / Q000008:administration & dosage*
chemical_list: D016915:AIDS Vaccines; D015483:HIV Antibodies; D019302:HIV Envelope Protein gp160; D012367:RNA, Viral; D019444:Vaccines, DNA